Table 2.
Comparison of platelet parameters in three groups.
| Laboratory values | Patients with vitamin D deficiency (N = 345) |
Patients without vitamin D deficiency(N = 362) |
Control subjects (100) |
P* | P** | P*** |
|---|---|---|---|---|---|---|
| Mean PLT ± SD (×103/μl) Min-Max |
318.2 ± 48.4 110.2-481.3 |
219.4 ± 56.6 100.5-375.2 |
266.1 ± 45.9 101.7-396.4 |
.021 | .042 | .033 |
| MPV ± SD, fL | 10.0 ± 0.6 | 8.6 ± 0.5 | 8.5 ± 0.9 | .038 | .038 | .967 |
| MPR | .031 | .039 | .032 | .133 | .229 | .727 |
| Mean lymphocyte ± SD (×103/μl) | 1.12 ± 8.5 | .94 ± 9.2 | 2.82 ± 7.7 | .369 | <.001 | <.001 |
| MLR | 8.9 | 9.1 | 3.0 | .107 | <.001 | <.001 |
| PLR | 284.1 ± 101.5 | 233.4 ± 132.3 | 94.3 ± 129.4 | .029 | <.001 | <.001 |
| PCT, % | 0.20 | 0.20 | 0.20 | .999 | .999 | 999 |
| MPV/PCT | 50.0 | 43.0 | 38.6 | .148 | .034 | .129 |
| PDW, % | 16.7 | 16.2 | 16.2 | .234 | .109 | .927 |
| PDW/PCT | 83.6 | 81.0 | 73.6 | .241 | .027 | .047 |
| PDW/PLT | .04 | .07 | .06 | .046 | .103 | .965 |
| Vitamin D*MPV | 171.0 | 295.8 | 299.2 | .002 | .002 | .341 |
| Vitamin D*PLT | 5441.2 | 7547.3 | 9366.7 | .011 | <.001 | .023 |
| Vitamin D*PDW | 285.5 | 557.2 | 570.2 | <.001 | <.001 | .982 |
| Mean AST ± SD, (IU/L) | 30.1 ± 10.2 | 31.3 ± 12.3 | 27.8 ± 9.7 | .667 | .387 | .255 |
| APRI | .09 | .14 | .10 | .037 | .738 | .072 |
PLT, platelet count; PCT, Plateletcrit; MPV, mean platelet volume; MPR, MPV/platelet count ratio; MLR, MPV to lymphocyte ratio; PLR, platelet-lymphocyte ratio; AST, aspartate aminotransferase; PDW, platelet distribution width; APRI, AST-to-PLT ratio index. * Denote the multiplication operation and the product is the average concentration of serum vitamin D in each group in each of the desired variables.
P* Patients with vitamin D deficiency vs. Patients without vitamin D deficiency.
P** Patients with vitamin D deficiency vs. Control subjects.
P*** Patients without vitamin D deficiency vs. Control subjects.